Evolution of the Average Target: Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

d89ba584e1fc718f3e.MfZaX7JdzcLMexqurebwpC_xiQ9SjYvZkSzRMqvsPwY.AZoLaPMYvLO6KSn4-t_F6Gmu-Ww7vNm88HWcZNvfd0R-sz9m4zmYrIIpLg~2b9a4e3222f90e6a0d5b8149906b2a2e
29/10/25 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
29/10/25 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
06/10/25 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
29/08/25 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
06/08/25 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
06/08/25 Stride Q4 revenue, adjusted EPS beat estimates RE
30/04/25 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
30/04/25 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
21/04/25 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
21/04/25 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
29/01/25 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
23/10/24 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
20/08/24 Stride Shares Fall After Citigroup Downgrade MT
20/08/24 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
08/08/24 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
08/08/24 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
31/07/24 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24/04/24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
25/01/24 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
25/01/24 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
24/01/24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
16/11/23 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
16/11/23 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT
26/10/23 BMO Capital Raises Price Target on Stride to $57 From $50, Maintains Outperform Rating MT
25/10/23 Barrington Raises Price Target on Stride to $60 From $50, After Q1/24 Earnings Top Estimates, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+24.73%
+45.43%
+51.21%
-0.52%
-7.64%
+19.37%
+35.76%
- - +23.21%
- +25%
+5.33%
Average +22.19%
Weighted average by Cap. +24.83%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
91.00USD
Average target price
113.50USD
Spread / Average Target
+24.73%
High Price Target
125.00USD
Spread / Highest target
+37.36%
Low Price Target
102.00USD
Spread / Lowest Target
+12.09%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BMO Capital
Morgan Stanley
Barrington Research
Citigroup
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
91.00USD
Average target price
113.50USD
Spread / Average Target
+24.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LRN Stock
  4. Consensus Stride, Inc.